<p>(<b>A, B</b>) An experiment as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003982#ppat-1003982-g002" target="_blank">Fig. 2</a> was performed for the combinations (black lines) of (<b>A</b>) AZT and TFV and (<b>B</b>) 3TC and ABC and compared to each single inhibitor treatment (red lines, left and right panel). The X-axis represents the drug concentration of the drug within the combination that is being compared to the single drug treatment (in red). See Supplementary <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003982#ppat.1003982.s008" target="_blank">Fig. S8A</a> for additional inhibitor combinations. (<b>C</b>) The change in IC<sub>90</sub> for co-culture over cell-f...
Background Effectiveness of ART regimens strongly depends upon complex interactions between the s...
The success of nucleoside reverse transcriptase inhibitors (NRTIs) in treating HIV-1 infection and r...
Background: Single-drug class regimens with nucleoside/nucleotide reverse transcriptase inhibitors (...
<p>(<b>A</b>) An experiment as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/jou...
<p>(<b>A</b>) The average instantaneous inhibitory potential (IIP) was calculated for each drug of <...
HIV-1 cell-to-cell transmission allows for 2–3 orders of magnitude more efficient viral spread than ...
<div><p>HIV-1 cell-to-cell transmission allows for 2–3 orders of magnitude more efficient viral spre...
The worldwide spread of human immunodeficiency virus (HIV) has spurred the search for effective drug...
The worldwide spread of human immunodeficiency virus (HIV) has spurred the search for effective drug...
A large variety of compounds have been reported to inhibit the replication of human immunodeficiency...
A mathematical model of the interaction among CD4+ T-cells, HIV-1, and antiretroviral drugs was fitt...
Nineteen HIV-seropositive antiretroviral therapy-naive and asymptomatic individuals (200-500 CD4/\u3...
Background Effectiveness of ART regimens strongly depends upon complex interactions between the sele...
By use of simulations we imputed human immunodeficiency virus type 1 drug resistance incidence to pr...
The success of nucleoside reverse transcriptase inhibitors (NRTIs) in treating HIV-1 infection and r...
Background Effectiveness of ART regimens strongly depends upon complex interactions between the s...
The success of nucleoside reverse transcriptase inhibitors (NRTIs) in treating HIV-1 infection and r...
Background: Single-drug class regimens with nucleoside/nucleotide reverse transcriptase inhibitors (...
<p>(<b>A</b>) An experiment as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/jou...
<p>(<b>A</b>) The average instantaneous inhibitory potential (IIP) was calculated for each drug of <...
HIV-1 cell-to-cell transmission allows for 2–3 orders of magnitude more efficient viral spread than ...
<div><p>HIV-1 cell-to-cell transmission allows for 2–3 orders of magnitude more efficient viral spre...
The worldwide spread of human immunodeficiency virus (HIV) has spurred the search for effective drug...
The worldwide spread of human immunodeficiency virus (HIV) has spurred the search for effective drug...
A large variety of compounds have been reported to inhibit the replication of human immunodeficiency...
A mathematical model of the interaction among CD4+ T-cells, HIV-1, and antiretroviral drugs was fitt...
Nineteen HIV-seropositive antiretroviral therapy-naive and asymptomatic individuals (200-500 CD4/\u3...
Background Effectiveness of ART regimens strongly depends upon complex interactions between the sele...
By use of simulations we imputed human immunodeficiency virus type 1 drug resistance incidence to pr...
The success of nucleoside reverse transcriptase inhibitors (NRTIs) in treating HIV-1 infection and r...
Background Effectiveness of ART regimens strongly depends upon complex interactions between the s...
The success of nucleoside reverse transcriptase inhibitors (NRTIs) in treating HIV-1 infection and r...
Background: Single-drug class regimens with nucleoside/nucleotide reverse transcriptase inhibitors (...